, Cancer statistics, vol.68, p.30, 2018.
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int J Cancer, vol.144, issue.8, pp.1941-1953, 2019. ,
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial, JAMA, vol.317, issue.23, pp.2392-2401, 2017. ,
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer, Ann Oncol, vol.25, issue.7, pp.1346-55, 2014. ,
Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma, Int J Colorectal Dis, vol.32, issue.8, pp.1179-1190, 2017. ,
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer, N Engl J Med, vol.360, pp.1408-1417, 2009. ,
Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306), Oncotarget, vol.8, issue.62, pp.105749-105760, 2017. ,
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials, Eur J Cancer, vol.70, pp.87-98, 2017. ,
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials, Ann Oncol, vol.28, issue.8, pp.1713-1729, 2017. ,
Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype, Expert Rev Anticancer Ther, 2018. ,
Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature, Gastroenterology Res, 2018. ,
Heterogeneity of colon cancer: from bench to bedside. ESMO Open, vol.2, p.218, 2017. ,
Primary tumor location as an independent prognostic marker from molecular features for overall survival in patients with metastatic colorectal cancer: Analysis of CALGB/SWOG 80405, ASCO Annual Meeting. Abstract 3503. Presented, 2017. ,
Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis, Cancer Med, 2018. ,
Mortality by stage for right versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-medicare data, J Clin Oncol, vol.29, issue.33, pp.4401-4410, 2011. ,
Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study, Int J Surg, vol.12, issue.9, pp.925-955, 2014. ,
Colon cancer in Icelande a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age, Int Journal Cancer Journal international du cancer, vol.127, pp.2645-53, 2010. ,
Does the primary site of colorectal cancer impact outcomes of patients with metastatic disease? Cancer, vol.121, pp.830-835, 2015. ,
The metastatic spread of cancers of the digestive system in man, Oncology, vol.35, issue.3, pp.114-140, 1978. ,
Patterns of metastasis in colon and rectal cancer. Sci Rep, vol.6, p.29765, 2016. ,
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival, Asia Pac J Clin Oncol, 2019. ,
Colorectal cancer liver metastases -a population-based study on incidence, management and survival, BMC Cancer, vol.18, p.78, 2018. ,
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study, Int J Cancer, 2011. ,
, Jun, vol.1, issue.11, pp.2717-2742
BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status, J Korean Med Sci, vol.32, issue.1, pp.38-46, 2017. ,
Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location, J Natl Compr Canc Netw, vol.14, issue.12, pp.1536-1543, 2016. ,
The consensus molecular subtypes of colorectal cancer, Nat Med, vol.21, pp.1350-1356, 2015. ,
Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study, Int J Colorectal Dis, 2018. ,
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from Analysis and Research in Cancers of the Digestive System (ARCAD) database, Lancet Oncol, vol.17, issue.12, pp.1709-1719, 2016. ,
Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers, Oncotarget, vol.8, issue.49, pp.86356-86368, 2017. ,
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma, Ann Thorac Surg, vol.78, issue.1, pp.238-282, 2004. ,
Actual 10 year survival after resection of colorectal liver metastases defines cure, J Clin Oncol, vol.25, pp.4575-80, 2007. ,
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients, Ann Surg, vol.250, pp.440-448, 2009. ,
Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?, J Thorac Cardiovasc Surg, vol.117, pp.66-75, 1999. ,
NCCN Guidelines Insights: Colon Cancer, Version 2, J Natl Compr Canc Netw, vol.16, issue.4, pp.359-369, 2018. ,
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making, Ann Oncol, vol.23, issue.10, pp.2479-516, 2012. ,
Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection, Ann Surg Oncol, vol.21, issue.5, pp.1632-1672, 2014. ,
Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study, Clin Colorectal Cancer, vol.15, issue.4, pp.165-174, 2016. ,
Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first, Clin Transl Oncol, vol.20, issue.10, pp.1274-1279, 2018. ,
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array, World J Gastroenterol, vol.18, pp.637-682, 2012. ,
A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis, Scand J Gastroenterol, vol.45, pp.217-242, 2010. ,
Left versus right side metastatic colorectal cancer. Teasing out clinicopathologic drivers of disparity in survival, 2019. ,